News and Events

First ATN event of 2021

The first Advanced Therapies Network meeting of 2021 will be held on Thursday 4th March 16:00 – 17:30 An expert panel will present their challenges around attracting, retaining and training talent in advanced therapies, where are the skills shortages? What can be done to train the next generation of talent to minimise the…

Advanced therapy education webinar series

Are you interested in learning more about cell and gene therapies -also known as advanced therapies? Join experts from across the UK for a free webinar series on advanced therapy medical products (ATMPs). Each short presentation (~20 mins) will be followed with time for Q&A with the speaker. Target audience:…

Emerging Hearing Medicines Landscape webinar

  Hosted by Cell and Gene Therapy Catapult and London Advanced Therapies Providing an introduction to the promise of cell and gene therapies for the treatment of hearing loss, and provide a forum for discuss the challenges and opportunities of this emerging therapeutic modality and its application for hearing loss.…

Introduction to ATMP Manufacturing webinar

10th December – 4pm The production of novel advanced therapy medicinal products (ATMPs) contrasts with established biomanufacturing processes for medicines that are synthetically derived (i.e. small molecule drugs) or proteins/peptides expressed by cellular systems (i.e. large molecule biopharmaceuticals). ATMPs present unique bioprocessing challenges such as limited scalability, variable quality of…

The Centre for Advanced Therapeutics at Imperial College London

The aim of the Centre is to increase the cohesion and critical mass of teams within Imperial College to catalyse translation of promising new ATMP treatments. Imperial College has already made major contributions in a wide range of key advanced therapeutic research areas including biomaterials, cardiology, haematology, neurology, respiratory, vaccines/…

Future Evolution of Laboratory Working

5 Nov 2020 4:00 pm – 5:30 pm Virtual   While COVID has presented many challenges for getting back safely to the lab or continuing research it has also become apparent that it has acted as a catalyst for change. Whether that be new ways of working, enhanced collaborations and…